Archives

by in
Entry Author Date Location
Thong Le Takes Over at Accelerator, With Eyes on Seattle and NYC 01/29/14 Seattle
Allozyne Garners $2,452,450 New Financing Round 08/19/13 Seattle
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Allozyne Lands $2,002,000 New Financing Round 06/04/12 Seattle
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics 03/21/12 Seattle
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan 01/03/12 Seattle
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles 12/23/11 Seattle
Allozyne Receives New Round 12/23/11 Seattle
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ 06/22/11 Seattle
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News 01/20/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders 12/13/10 San Diego
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Allozyne’s Next Drug, Made to Kill Two Birds With One Stone, Being Prepped for Clinic 11/16/10 Seattle
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Our Top 20 Stories of the Third Quarter: What’s Making Waves in the NW’s Tech and Biotech Sectors 09/30/10 Seattle
Lee Hood & Team Moving to South Lake Union, Mirina Vs. Marina, Trubion Gets Acquired, & More Seattle-Area Life Sciences News 08/19/10 Seattle
Allozyne Inks Sigma-Aldrich Deal 08/12/10 Seattle
Biotech on a Shoestring: How Companies Are Pinching Pennies in the “New Reality” 07/21/10 Seattle
Allozyne Breaks Silence, Accelerator’s Mini-Golf Hijinks, Maveron’s Vision for Primary Care, & More Seattle-Area Life Sciences News 07/15/10 Seattle
Allozyne Licenses Scripps Chemistry 07/14/10 Seattle
Page 1 of 2 next page »